Day-to-Day Assessment and Management of Decompensated Liver Disease: A Practical Guide for Medical Interns

Dr Neeraj Manikath 

 Abstract

Decompensated liver disease, often manifesting as cirrhosis with complications such as ascites, hepatic encephalopathy (HE), variceal bleeding, spontaneous bacterial peritonitis (SBP), and hepatorenal syndrome (HRS), represents a critical phase of chronic liver injury with high morbidity and mortality. This review provides a comprehensive overview tailored for medical interns on ward duty, emphasizing systematic daily assessment, evidence-based management strategies, and practical tips to optimize patient outcomes. Drawing from major guidelines including those from the European Association for the Study of the Liver (EASL) and the American Association for the Study of Liver Diseases (AASLD), we highlight key pathophysiology, diagnostic approaches, therapeutic interventions, and prognostic tools. Special sections on "pearls" (valuable insights), "oysters" (potential pitfalls), and "hacks" (ward-efficient shortcuts) are included to enhance real-world application. Early recognition of precipitants, multidisciplinary care, and timely referral for liver transplantation are pivotal to reducing in-hospital mortality, which ranges from 10-20%.

 Introduction

Decompensated liver disease typically arises in the context of cirrhosis, where the liver's compensatory mechanisms fail, leading to life-threatening complications. It affects approximately 5-10% of patients with compensated cirrhosis annually, with a median survival of about 2 years once ascites develops. Common etiologies include alcohol-related liver disease, non-alcoholic steatohepatitis (NASH), viral hepatitis (HBV/HCV), and autoimmune conditions. Decompensation is often precipitated by infections (30-57% of cases), gastrointestinal bleeding, alcohol intake, or medication non-adherence. For interns, managing these patients on the ward involves a structured approach: initial stabilization using ABC (airway, breathing, circulation) principles, identification of triggers, and daily monitoring to prevent progression to acute-on-chronic liver failure (ACLF), which carries a 50% mortality rate. This article synthesizes current guidelines to equip interns with tools for effective day-to-day care, focusing on assessment, management, and practical nuances.

Pathophysiology

Decompensated liver disease evolves from chronic hepatic injury causing fibrosis, nodule formation, and disruption of normal liver architecture. Key mechanisms include:

Portal Hypertension: Increased resistance to portal blood flow leads to splanchnic vasodilation via nitric oxide and prostaglandins, resulting in effective hypovolemia, activation of the renin-angiotensin-aldosterone system (RAAS), and antidiuretic hormone (ADH) release. This promotes sodium and water retention, manifesting as ascites and hyponatremia.

Systemic Inflammation and Immune Dysfunction: Bacterial translocation from the gut (due to altered microbiota and permeability) triggers a cytokine storm, exacerbating vasodilation and organ dysfunction. This is central to ACLF, defined as acute decompensation with organ failures.

Multi-Organ Involvement: Renal impairment (e.g., HRS from renal vasoconstriction), cerebral edema (HE from ammonia toxicity and GABAergic imbalance), coagulopathy (imbalanced pro- and anti-coagulant factors), and cardiopulmonary complications (e.g., hepatopulmonary syndrome [HPS] or portopulmonary hypertension [PPHT]) ensue.

Understanding these pathways guides management: removing etiologic factors (e.g., alcohol abstinence, antivirals for HBV/HCV) can reverse decompensation in some cases.

 Daily Clinical Assessment

A systematic daily evaluation is crucial for early detection of complications and response to therapy. Use the British Society of Gastroenterology (BSG) care bundle for the first 24 hours to standardize care and improve outcomes.

History and Physical Exam: Inquire about symptoms (abdominal pain, dyspnea, confusion, melena, alcohol use) and precipitants (infection, constipation, non-adherence). Examine for vital signs (hypotension/tachycardia indicating sepsis or bleed), ascites grading (1: ultrasound-only; 2: moderate; 3: tense), HE (West Haven criteria: grade 1-4 based on orientation and asterixis), jaundice, edema, and signs of infection (fever, tenderness). Assess volume status via jugular venous pressure, mucous membranes, and postural changes.

Laboratory Monitoring: Daily: complete blood count (CBC) for anemia/infection, comprehensive metabolic panel (CMP) for bilirubin, albumin, electrolytes (Na <130 mmol/L signals poor prognosis), creatinine (SCr; rise ≥0.3 mg/dL indicates AKI), international normalized ratio (INR), and inflammatory markers (C-reactive protein, procalcitonin). Urine output/sodium, ammonia (not diagnostic for HE), and ascitic fluid analysis if indicated. Use baseline SCr from prior 3 months.

Imaging and Procedures: Abdominal ultrasound for ascites, portal vein patency, and hepatocellular carcinoma (HCC) screening. Esophagogastroduodenoscopy (EGD) for varices on first decompensation. Diagnostic paracentesis on admission for all with ascites (neutrophils >250/mm³ = SBP). Thoracentesis for hepatic hydrothorax if dyspnea.

Prognostic Scoring: Calculate daily/weekly: Model for End-Stage Liver Disease with Sodium (MELD-Na) for transplant priority; Child-Pugh for severity; CLIF-C OF for ACLF grading (grades I-III based on organ failures). Red flags: worsening scores, organ failures—escalate to hepatology/ICU.

 Management of Key Complications

Management is complication-specific, with emphasis on supportive care, precipitant removal, and liver transplant referral (e.g., MELD ≥15 or refractory complications).

Ascites

Assessment: Grade daily; diagnostic paracentesis if new/worsening (serum-ascites albumin gradient [SAAG] ≥1.1 g/dL confirms portal hypertension).

Management: Sodium restriction (80-120 mmol/day). For grade 2: spironolactone 100-400 mg/day ± furosemide 40-160 mg/day (5:2 ratio; target 0.5-1 kg/day loss). For grade 3/refractory: large-volume paracentesis (LVP) with albumin 6-8 g/L removed if >5 L to prevent post-paracentesis circulatory dysfunction. Consider transjugular intrahepatic portosystemic shunt (TIPS) as bridge to transplant. For hepatic hydrothorax: thoracentesis; avoid chest tubes.

 Hepatic Encephalopathy

Assessment: Grade daily (West Haven); check for precipitants (infection, constipation, hypokalemia).

- Management: Lactulose titrated to 2-3 soft stools/day; add rifaximin 550 mg twice daily if recurrent. Correct electrolytes; avoid sedatives. For grade 3-4: consider intubation.

 Variceal Bleeding

Assessment: Assume variceal in cirrhosis with GI bleed; monitor hemoglobin, melena.

Management: Resuscitate with fluids/blood (target Hb 7-8 g/dL); terlipressin/octreotide; antibiotics (ceftriaxone 1 g/day x7 days). Urgent EGD with band ligation; balloon tamponade if uncontrolled. Prophylaxis: non-selective beta-blockers (NSBBs; e.g., propranolol titrated to HR 55-60 bpm) + banding. Caution with NSBBs in refractory ascites (discontinue if SBP <90 mmHg).

 Infections and SBP

- Assessment: Screen all admissions (cultures, ascitic tap); high suspicion for nosocomial multidrug-resistant organisms.

- Management: Empiric broad-spectrum antibiotics (e.g., ceftriaxone for SBP); albumin 1.5 g/kg day 1 + 1 g/kg day 3. Prophylaxis: norfloxacin if high-risk (ascites protein <1.5 g/dL + renal impairment).

Hepatorenal Syndrome and AKI

Assessment: Stage AKI (International Club of Ascites criteria); exclude prerenal/acute tubular necrosis.

- Management: Hold diuretics/nephrotoxins; albumin challenge (1 g/kg x2 days). If HRS: terlipressin/octreotide + albumin; midodrine for hypotension. Dialysis as bridge to transplant.

 Nutrition and Other Supportive Care

Assessment: Screen for malnutrition (dry-weight BMI <18.5 kg/m²; sarcopenia tools).

Management: 35-40 kcal/kg/day, 1.2-1.5 g protein/kg/day; oral supplements or nasogastric feeding. Thiamine for alcohol-related cases. Palliative symptom control: menthol lotion for pruritus; oxygen for HPS (PaO₂ <60 mmHg).

 Pearls, Oysters, and Hacks

 Pearls (Valuable Insights)

- Asterixis is diagnostic for ≥grade 2 HE; always check for it daily.

- Restrictive transfusion (Hb >7 g/dL) in variceal bleed reduces rebleeding risk.

- Albumin infusion in SBP or LVP prevents HRS and improves survival.

- MELD-Na outperforms Child-Pugh for short-term prognosis; recalculate daily for transplant discussions.

- Etiologic treatment (e.g., antivirals for HBV) can lead to recompensation in select cases.

- Consider thromboembolic complications in patients with cirrhosis, even if INR is elevated.

- Use low doses of NSBBs in advanced cirrhosis to improve survival, unless severe hypotension is present.

- Screen for malnutrition using dry-weight BMI and ensure adequate protein intake (1.2–1.5 g/kg/day).

- Administer anticoagulants for portal vein thrombosis after variceal prophylaxis to prevent progression.

- Always check acetaminophen levels in suspected liver failure, as therapeutic levels don't rule out toxicity.

 Oysters (Pitfalls to Avoid)

- Overuse of PPIs increases SBP and HE risk; reserve for clear indications like ulcers.

- Delaying paracentesis >12 hours raises mortality; perform on admission despite coagulopathy (no routine correction needed).

- Indiscriminate NSBB use in advanced disease (e.g., SBP <90 mmHg) worsens hemodynamics; titrate carefully.

- Neglecting comorbidities (e.g., diabetes) exacerbates decompensation; screen multidisciplinary.

- Fluid restriction for hyponatremia is ineffective if poor adherence; monitor thirst and use albumin instead.

- Relying on normal ammonia levels to rule out hepatic encephalopathy.

- Delaying antibiotic therapy for nosocomial infections due to subtle symptoms.

- Withholding N-acetylcysteine when paracetamol poisoning cannot be excluded.

- Failing to correct even mild hypokalemia, which contributes to hyperammonemia.

- Using sedating medications like benzodiazepines in patients with hepatic encephalopathy.

 Hacks (Ward Shortcuts)

- Use a daily checklist: Vitals, weight, fluid balance, labs (SCr/Na/K), HE grade, BMs (target 2-3 for lactulose).

- For AKI: Quick urine Na (<10 mmol/L suggests HRS); start albumin challenge immediately.

- Bedside cultures in blood bottles for ascites improve SBP detection; no need for large volumes.

- Midodrine (7.5-15 mg TID) + octreotide for HRS as a rapid ward intervention before escalation.

- Nutrition hack: Six small meals/day with late-night snack to prevent catabolism; consult dietitian early.

Conclusion

Effective management of decompensated liver disease on the ward hinges on vigilant daily assessment, prompt intervention for complications, and adherence to guidelines. For interns, integrating pearls like early paracentesis with avoiding oysters such as PPI overuse can significantly impact outcomes. Multidisciplinary involvement and timely transplant referral are essential, as many patients can achieve recompensation or successful transplantation. Future research may refine biomarkers and therapies, but current strategies emphasize prevention and supportive care.

 References

This review is based on the following key sources, cited inline where applicable:

1. Angeli P, et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406-460.

2. Biggins SW, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74(2):1014-1048.

3. Rogal SS, et al. AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis. Hepatology. 2022;76(3):819-836.

4. D'Amico G, et al. Clinical states of cirrhosis and competing risks. J Hepatol. 2018;68(3):563-576.

5. Moreau R, et al. Acute-on-chronic liver failure: Recent update. J Clin Exp Hepatol. 2017;7(1):1-6.

6. Ginès P, et al. Mistakes in decompensated liver cirrhosis and how to avoid them. UEG J. 2019;7(9):1185-1193.

7. Acute Liver Failure. RCEMLearning. Accessed October 19, 2025.

8. Liver Emergencies: Acute Liver Failure, Hepatic Encephalopathy, Hepatorenal Syndrome, Liver Test Interpretation & Drugs to Avoid. Emergency Medicine Cases. November 2020.